89th Legislature

HB 3812

Overall Vote Recommendation
No
Principle Criteria
Free Enterprise
Property Rights
Personal Responsibility
Limited Government
Individual Liberty
Digest

HB 3812 makes targeted reforms to the preauthorization and utilization review process used by health insurers and health maintenance organizations (HMOs) in Texas. The bill strengthens physician autonomy and aims to improve access to medically necessary healthcare by reducing burdensome preauthorization requirements for high-performing healthcare providers. Specifically, HB 3812 requires that all utilization reviews be conducted under the direction of a physician licensed to practice medicine in Texas, explicitly excluding those with only an administrative medicine license. This ensures that clinical decisions are overseen by professionals with current medical experience and direct patient care expertise.

The bill also expands the time frame used to evaluate whether a provider qualifies for a preauthorization exemption. Under the new law, insurers must use a one-year evaluation period, up from six months, and grant an exemption from prior authorization requirements for specific services if the provider received approval for at least 90% of preauthorization requests and performed the service at least five times during that time. These reforms aim to reward physicians with a consistent track record of providing medically necessary care and reduce unnecessary delays for patients.

To ensure fairness and accountability, the bill restricts the timing and conditions under which exemptions may be rescinded. Reviews to rescind exemptions must be based on a statistically valid random sampling and overseen by a physician with appropriate specialty credentials. In addition, the bill guarantees physicians and providers the right to seek independent third-party reviews of adverse determinations without first exhausting internal insurer appeal processes. Lastly, the bill mandates annual public reporting of exemption data to the Texas Department of Insurance, which enhances transparency in the health plan review process.

Author
Greg Bonnen
Tom Oliverson
Venton Jones
Co-Author
Robert Guerra
Cody Harris
Carrie Isaac
Janie Lopez
William Metcalf
Sponsor
Kelly Hancock
Co-Sponsor
Nathan Johnson
Charles Schwertner
Fiscal Notes

According to the Legislative Budget Board (LBB), HB 3812 is projected to have no net impact on General Revenue-related funds through the biennium ending August 31, 2027. While the bill does not make an appropriation itself, it provides the legal framework for implementing an expanded reporting system within the Texas Department of Insurance (TDI). The bill requires insurers and health maintenance organizations to submit annual reports on preauthorization exemptions and related determinations, creating a need for new administrative infrastructure.

To support this mandate, TDI would need to develop and maintain a new dedicated reporting system database capable of handling a significant volume of data submissions. With approximately 3,000 healthcare services per plan and numerous reporting entities, TDI anticipates substantial reporting activity. The estimated fiscal impact includes a one-time system development cost of $900,000 in FY 2026 and an ongoing annual maintenance cost of $150,000 in subsequent years. These expenditures would be drawn from the Department of Insurance Operating Account (Fund 36), a self-leveling fund supported by maintenance taxes assessed on insurers.

Because Fund 36 is self-leveling, any increased expenditures resulting from the bill would be offset by corresponding adjustments in maintenance tax rates for regulated insurers. Therefore, while there are notable implementation and operational costs, they are fully accounted for within the fund’s revenue structure and do not affect general revenue. Additionally, no significant fiscal impact is anticipated for local governments as a result of this legislation.

Vote Recommendation Notes

HB 3812, though presented as a refinement of the 2021 "gold card" law, meaningfully expands the role of state government in private-sector healthcare regulation. While the bill’s stated intent is to reduce administrative burdens for physicians and improve care delivery, it does so through mechanisms that ultimately increase state oversight of private insurance operations, impose new compliance mandates, and expand the regulatory apparatus at the Texas Department of Insurance (TDI). These changes raise significant concerns for lawmakers committed to limited government, free enterprise, and minimal regulatory interference.

One of the most problematic aspects of HB 3812 is its mandate that health maintenance organizations and insurers annually report detailed data on preauthorization exemptions, rescissions, and independent reviews. This new reporting requirement—coupled with the volume of data anticipated, spanning thousands of health services per plan—imposes a non-trivial compliance burden on private insurers. It represents a shift away from market-based accountability toward bureaucratic micromanagement. This move undermines the principle that private actors should be free to structure their operations and relationships with providers within the bounds of consumer choice and competition—not state-mandated uniformity.

The bill also necessitates the creation of a new government-managed reporting database. The fiscal note acknowledges an initial $900,000 cost for this build-out, followed by $150,000 in recurring annual expenses. Even though these costs will be absorbed by the Department of Insurance Operating Account (Fund 36), a self-leveling fund financed through maintenance taxes on insurers, it is functionally a pass-through cost likely to be borne indirectly by consumers through higher premiums. This introduces an expanded government footprint in the health insurance marketplace, without adequate safeguards to prevent future mission creep or cost escalation.

Moreover, HB 3812 overrides insurer discretion in determining how preauthorization exemptions are granted and when they can be rescinded. By statutorily defining review timeframes, sample sizes, and the credentials of reviewing physicians, the bill injects the state directly into the operational design of health plans. This shift further limits the ability of insurers to innovate, respond to fraud, or tailor clinical oversight to their risk tolerance and business models. While well-intentioned, the approach prioritizes uniformity over flexibility and further entangles the state in the administration of private contracts.

Perhaps most importantly, the bill sets a concerning precedent for future legislative intervention in healthcare administration. Though HB 3812 is framed narrowly, it normalizes the idea that the legislature, not patients, providers, or insurers, should dictate the operational details of medical service review. This opens the door to further expansions in state oversight of claims processes, billing, and utilization review policy, drifting toward a model of centralized regulation that is antithetical to principles of private-sector autonomy and individual responsibility.

In conclusion, while HB 3812 seeks to address legitimate frustrations with prior authorization processes, it does so in a manner that grows the regulatory state, imposes new burdens on private businesses, expands government infrastructure, and reduces private-sector flexibility. These outcomes are inconsistent with the core liberty principles of limited government, free enterprise, and personal responsibility. For these reasons, Texas Policy Research recommends that lawmakers vote NO on HB 3812.

  • Individual Liberty: On the surface, the bill appears to enhance individual liberty by exempting certain physicians from burdensome preauthorization requirements, theoretically improving patient access to timely care. However, this improvement comes at the cost of increased government control over how private insurers operate. Rather than empowering individuals through deregulation, the bill shifts authority from private actors to the state, creating new requirements for insurers and narrowing their contractual freedom. This substitution of state mandates for private negotiation represents a net loss in liberty for insurers and consumers who prefer market-based models of healthcare management.
  • Personal Responsibility: The bill undercuts personal responsibility by mandating a one-size-fits-all model for how insurers evaluate and exempt providers from prior authorization. Rather than allowing insurers to develop individualized risk-based models for exemption, the bill enforces a state-defined performance threshold (90% approval rate) and procedural rules for rescission. This top-down approach removes the burden of responsible decision-making from private actors and replaces it with state direction. It presumes that uniform regulation is more effective than tailored, contract-based accountability and discourages adaptive practices that promote innovation and individualized responsibility.
  • Free Enterprise: The bill creates a significant new reporting burden on insurers and HMOs, compelling them to submit detailed annual data to the Texas Department of Insurance on thousands of healthcare services per plan. This reporting mandate, combined with required IT infrastructure build-out, increases compliance costs and reduces operational flexibility. These measures not only expand the regulatory footprint of the state in private healthcare markets but also signal a trend toward more active legislative involvement in how insurers do business. The result is a clear erosion of free enterprise, as the competitive discretion of private firms is subordinated to uniform state policy.
  • Private Property Rights: The bill does not directly interfere with land ownership or physical property. However, it does compel private businesses, insurers, to dedicate resources (data, time, personnel, and money) toward government-mandated reporting and compliance systems. While this doesn’t rise to the level of eminent domain or asset seizure, it arguably encroaches on how private entities deploy their internal resources and intellectual property (e.g., claims data), raising concerns about creeping regulatory intrusion. Still, these effects are indirect, so the bill's impact on this principle is best rated as neutral.
  • Limited Government: The bill expands the scope of state involvement in healthcare administration. It requires the creation of a new reporting database at the Department of Insurance (with a one-time $900,000 build cost and $150,000 in annual maintenance), mandates new annual reports from private insurers, and prescribes detailed procedures for when and how insurers may rescind exemptions. These are clear examples of increased bureaucratic infrastructure, data surveillance, and administrative rulemaking. Even though the bill does not grow general revenue spending, it institutionalizes new layers of oversight and reduces the autonomy of private actors—marking a clear departure from limited government principles.
View Bill Text and Status